August 1, 2021: Dr. Douglas McCarty is joining NeuroGT as the CSO to lead the R&D and CMC in the company’s rare disease gene therapy platform.
- Telphone : 740-497-3515
- info@neurogt.com
www.NeuroGT.com - NeuroGT Company Website
August 1, 2021: Dr. Douglas McCarty is joining NeuroGT as the CSO to lead the R&D and CMC in the company’s rare disease gene therapy platform.